Insights on Dow 30 & Select Emerging Opportunities

All Johnson & Johnson Articles

Johnson & Johnson To Stop Selling Clean & Clear Fairness & Neutrogena Fine Fairness Lines

As per reports, Johnson & Johnson (JNJ) to stop selling skin whitening creams which are very popular in Asia and the Middle East after such products gained social pressure in recent weeks amid debate about racial inequality globally. The company to stop selling its Clean & Clear Fairness lin...

European Health Regulators Bless J&J’s Ebola Vaccine

As per reports, Johnson & Johnson's (JNJ) two-dose experimental vaccine for Ebola in the European Union has received approval from the European health regulators. The vaccine is prepared to target the Ebola strain that causes the disease in most people, J&J submitted the approval application...

Johnson & Johnson’s Baby Powder Will Continue To Be Sold in U.K

Reportedly, healthcare giant Johnson & Johnson (JNJ) to continue selling its talc-based Johnson's Baby Powder in the UK and the rest of the world, after facing ban in the US and Canada. The component talc which is mined from the earth and is found close to that of asbestos, known to cause cance...

J&J Beat Estimates, Lowers Full Year Guidance, & Raises Dividend

Johnson & Johnson (JNJ) recently released its quarterly earnings which beat market estimates. JNJ also made the decision to raise its dividend from $.95 cents a share to $1.01. The company forecasted 2020 adjusted earnings will reach the $7.50 to $7.90 per share level, much lower than its prior ...

J&J Announces Lead COVID-19 Vaccine Candidate Committing More Than $1B To Co-fund Development

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Johnson & Johnson (JNJ) announced that it has selected a lead COVID-19 vaccine candidate whic...

Johnson & Johnson Reports Earnings, Beats Wall Street Profit Estimates But Misses On Revenue

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Johnson & Johnson reported its fiscal Q4 profit results, beating Wall Street’s expectations...

J&J’s Janssen Pharmaceutical Companies To Provide 200k Ebola Vaccine Regimens to the Republic of Rwanda

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Reportedly, Johnson & Johnson’s Janssen Pharmaceutical Companies is set to provide 200k Ebo...

J&J Exceeds Q3 Expectations/Raises Full-Year Forecasts In the Face Of Legal Issues

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. On Tuesday, Johnson & Johnson reported their successful Q3 earnings, confirming that they had...

J&J Ordered To Pay Record Amount For Its Antipsychotic Drug Believed To Have Caused Gynecomastia

Reportedly, Johnson & Johnson has been asked to pay $8 billion as penalty charges to Nicholas Murray,who previously won $680,000 over his claims where J&J failed to alert young men over usage of its antipsychotic drug Risperdal causing gynecomastia, growth enlargement of male breasts, in a v...

Johnson & Johnson Comes to $10M Settlement In Ohio

Reportedly, JJohnson & Johnson (JNJ) along with its Janssen Pharmaceutical Companies have entered a settlement agreement with the Ohio counties of Cuyahoga and Summit settling all the claims for a combined payment of $10 million with no further admission of liability. The settlement has also rem...

J&J Charged With Penalty Of $572 Million By Oklahoma Court Over Opioid Crisis

Reportedly, Johnson & Johnson (JNJ) along with its subsidiaries have been charged with a penalty of $572 million for fueling the opioid crisis in the state of Oklahoma by Thad Balkman, Cleveland County District Judge on Monday. "The opioid crisis has ravaged the state of Oklahoma,". "It mus...

Johnson & Johnson Beats Expectations & Raises Full-Year Sales Forecast

Recently, Johnson & Johnson (JNJ) lifted its full-year sales forecast 2019 as its cancer drugs Darzalex and Imbruvica beat the sales forecast for the second-quarter earnings. The recent approval of its cancer drug Erleada for J&J's pharmaceuticals unit proved to help push earnings to beat ...

J&J Continuing Research For Mid-Stage HIV Vaccine

As per reports, Johnson & Johnson (JNJ) is staged to move forward with a late-stage study of an investigational vaccine for Human Immunodeficiency Virus (HIV), a condition that weakens the immune system of the body in countries like America and Europe. The company is continuing its research...

Israeli’s Nutritional Insights Provider DayTwo Raises $31 Million Funding via Seventure Partners & Johnson & Johnson

Reportedly, Israel's DayTwo raised $31 million in private financing bringing in a total of $48 million funding for the health tech start-up. DayTwo existing investors Seventure Partners and Johnson & Johnson were also participants at the event. DayTwo provides nutritional insights on intestina...

The Intercontinental Exchange (ICE) Launches The NYSE Board Advisory Council

Reportedly, The Intercontinental Exchange (ICE) parent company of NYSE recently announced the launch of the NYSE Board Advisory Council to connect board candidates with NYSE-listed companies and conduct live networking sessions to promote diversity among corporate boards. The advisory council cons...

The New York Jury Awards $325 Million To Couple from J&J For Asbestos Exposure

As per reports, St. Louis-based mesothelioma law firm of Maune Raichle Hartley French & Mudd representing Donna and Robert Olson on their claim of lifetime exposure to asbestos causing terminal mesothelioma due to the usage of Johnson’s Baby Powder and Shower won a $325 million award in New ...

Oklahoma Attorney General Mike Hunter Files Multibillion-dollar “Opioid” Case Against J&J

Reportedly Johnson & Johnson (JNJ) has been accused of using deceitful methods to encourage the over-use of opioid painkillers that has led to a U.S. opioid epidemic. Mike Hunter, Oklahoma Attorney General recently filed a  multi-billion dollar case demanding J&J to pay for helping cau...

J&J Accelerates Quarterly Profits

Recently, Johnson & Johnson (JNJ) announced that their Q1 earnings which exceeded market expectations. The company highlighted how their drug Stelara, used for the treatment of psoriasis and Crohn's disease, enjoyed a double-digit increase of about 32% bringing it to  $1.41 billion & now ...

“Earnings, Earnings, Earnings” – Vista Partners Daily Market Recap 4/16/2019

Stocks ended the day up today, with all three of the major indices notching gains. The Nasdaq finished the session with an increase of 0.30% (24.21 points). Meanwhile, the S&P 500 climbed 0.05% (1.48 points) to end the session. The Dow closed out the day up 0.26% (67.89 points). Earnings cont...

FDA Approves Johnson & Johnson’s Advanced Bladder Cancer Drug

According to The American Cancer Society’s website estimates for bladder cancer in the United States for 2019 are about 80,470 new cases of bladder cancer (about 61,700 in men and 18,770 in women and about 17,670 deaths from bladder cancer (about 12,870 in men and 4,800 in women. The rates of n...

Did Johnson & Johnson’s Shampoo Fail A Quality Test By The Indian Organization?

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. A Reuters story reported that a quality test conducted by The Rajasthan Drugs Control Organisat...

Current Beats, Meets & Misses of Dow 30 Company Q4 Earnings Reports (1-25-19)

With the fourth quarter of the fiscal year having come to a close we are squarely in the "earnings season' again.  The components of the Dow 30  have also begun releasing their current Q4 earnings reports and we have seen seven of the Dow 30 components beat  estimates, one company meet estimates...

J&J Announces Q1 2019 Dividend

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Johnson & Johnson started the New Year off by announcing that its Board of Directors has de...

J&J to Present at JP Morgan Health Care Conference In San Francisco January 7th, 2019

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Johnson & Johnson will be a participant in the 37th Annual JP Morgan Health Care Conference...

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us